The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 35
- 35 new
- Median first-year cost
- $122,813
- $4,350,306 in all
- Institutions
- 27
- 34 contact PIs
Awards by fiscal year
0
0
0
6
13
9
7
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY5
- BETH ISRAEL DEACONESS MEDICAL CENTER3
- OREGON HEALTH & SCIENCE UNIVERSITY2
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH2
- ARIZONA VETERANS RESEARCH AND EDUCATION FOUNDATION1
and 22 other institutions
Most frequent study sections
- Special Emphasis Panel (ZHL1 CSR-B (M1))8
- Special Emphasis Panel (ZHL1 CSR-Z (M3))7
- Special Emphasis Panel (ZHL1 CSR-S (S1))6
- Special Emphasis Panel (ZHL1 CSR-B (S1))5
- Special Emphasis Panel (ZHL1 CSR-R (M2))5
and 1 other study section
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2020 | Elucidating the Role of Inherited Complement System Defects in the Molecular Pathophysiology of Sepsis and Purpura Fulminans1R21HL153655-01 | Bendapudi, Pavan | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | First-year cost $131,250 | Study section ZHL1 |
| FY2020 | Exploration of Race, Obesity, and Metabolomics on the Development of Iron Deficiency in Young Women1R21HL153654-01 | Powers, Jacquelyn M | BAYLOR COLLEGE OF MEDICINE, TX | First-year cost $127,785 | Study section ZHL1 |
| FY2020 | Genotype-dependent cardiovascular and anti-inflammatory effects of fenofibrate1R21HL153559-01 | Doria, Alessandro | JOSLIN DIABETES CENTER, MA | First-year cost $126,750 | Study section ZHL1 |
| FY2020 | The Effect of Behavioral Weight Loss on Circulating Extracellular RNA1R21HL147831-01A1 | Freedman, Jane E | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | First-year cost $125,625 | Study section ZHL1 |
| FY2020 | Evaluation of alternative complement activity within an ARDS cohort1R21HL148088-01A1 | Lee, Janet SojungNouraie, Seyed Mehdi | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $124,139 | Study section ZHL1 |
| FY2020 | A Role for Glycemic Variation in Optimizing Management of Diabetes and Vascular Complications1R21HL150374-01A1 | Reaven, Peter DZhou, Jin | UNIVERSITY OF ARIZONA, AZ | First-year cost $122,816 | Study section ZHL1 |
| FY2020 | Lysophosphatidylcholines and Cognition (L-COG) Study1R21HL153471-01 | Semba, Richard D | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $122,813 | Study section ZHL1 |
| FY2019 | Biomarkers of Interstitial Lung Abnormalities Predict Poor Outcomes in ARDS.1R21HL145246-01A1 | Baron, Rebecca M | BRIGHAM AND WOMEN'S HOSPITAL, MA | First-year cost $172,770 | Study section ZHL1 |
| FY2019 | Using GenTAC Resources in BioLINCC to discover BAV-specific Aortic Phenotypes1R21HL150373-01 | Body, Simon C | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | First-year cost $131,250 | Study section ZHL1 |
| FY2019 | Siglec 9 for the diagnosis of ARDS1R21HL148488-01 | Shahul, Sajid | UNIVERSITY OF CHICAGO, IL | First-year cost $121,500 | Study section ZHL1 |
| FY2019 | PREDICTION OF OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF): A NEW PLASMA BIOMARKER1R21HL145217-01A1 | Cresci, SharonPeterson, Linda Ruth | WASHINGTON UNIVERSITY, MO | First-year cost $117,782 | Study section ZHL1 |
| FY2019 | Role of Methionine Sulfoxide and Advanced Glycation Endproducts in Cardiovascular and Renal Complications of Type 2 Diabetes1R21HL150268-01 | Koska, JurajReaven, Peter D | ARIZONA VETERANS RESEARCH AND EDUCATION FOUNDATION, AZ | First-year cost $117,147 | Study section ZHL1 |
| FY2019 | Exploration of key proteases and validation of biomarkers in genetically triggered thoracic aortic aneurysms1R21HL148363-01 | Ikonomidis, John S | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | First-year cost $116,625 | Study section ZHL1 |
| FY2019 | Diagnostic classifiers for sarcoidosis using a novel T7 phage display technology1R21HL148089-01 | Samavati, Lobelia | WAYNE STATE UNIVERSITY, MI | First-year cost $115,500 | Study section ZHL1 |
| FY2019 | Epigenetic Contributions to Bicuspid Valve Aortopathy in Turner Syndrome1R21HL148093-01 | Maslen, Cheryl L | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $115,500 | Study section ZHL1 |
| FY2019 | Sex Chromosome Loss and Clonal Hematopoesis in Thoracic Aortic Disease1R21HL150383-01 | Prakash, Siddharth Kumar | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | First-year cost $115,500 | Study section ZHL1 |
| FY2018 | The role of p53 in Iron Overload1R21HL144991-01 | Murphy, Maureen E. | WISTAR INSTITUTE, PA | First-year cost $150,165 | Study section ZHL1 |
| FY2018 | The Effects of the DASH Diet and Sodium Reduction on Subclinical Cardiac Damage1R21HL144876-01 | Juraschek, Stephen P | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | First-year cost $131,250 | Study section ZHL1 |
| FY2018 | Dietary Biomarkers and Cardioprotective Mechanisms of the DASH-Sodium Diet.1R21HL143089-01 | Rebholz, Casey Marie | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $129,706 | Study section ZHL1 |
| FY2018 | Urine galectin-3 as a biomarker of cardio-renal phenotype and prognosis1R21HL143092-01 | Rao, VeenaTestani, Jeffrey M | YALE UNIVERSITY, CT | First-year cost $125,625 | Study section ZHL1 |
| FY2018 | TNF-UMOD interactions and susceptibility to salt-induced hypertension1R21HL140260-01A1 | Ferreri, Nicholas R | NEW YORK MEDICAL COLLEGE, NY | First-year cost $123,000 | Study section ZHL1 |
| FY2018 | Personalized molecular approaches to disease monitoring and maintenance therapies for Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) patients undergoing allogeneic bone marrow transp1R21HL143096-01 | Gondek, Lukasz Pawel | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $122,813 | Study section ZHL1 |
| FY2018 | Prognostic Role of Plasma Xanthine Oxidoreductase in ARDS Patients1R21HL145216-01 | Gao, LiHassoun, Paul M. | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $122,813 | Study section ZHL1 |
| FY2018 | Anti-Mullerian Hormone in the Female Participants of the Multi-Center Study of Hydroxyurea1R21HL144973-01 | Lanzkron, Sophie MPecker, Lydia | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $122,812 | Study section ZHL1 |
| FY2018 | Determination of immunogenic microbiota in the lung: leveraging the Lung HIV Microbiome Project1R21HL143091-01 | Methe, BarbaraMorris, Alison | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $117,375 | Study section ZHL1 |
| FY2018 | Modulation of Iron Overload by Hepcidin and Erythroferrone1R21HL145232-01 | McLaren, Christine E. | UNIVERSITY OF CALIFORNIA-IRVINE, CA | First-year cost $116,455 | Study section ZHL1 |
| FY2018 | The genetic basis of sex bias for bicuspid aortic valve1R21HL142938-01 | Maslen, Cheryl L | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $115,500 | Study section ZHL1 |
| FY2018 | Water T2 as a Global Biomarker for Cardiometabolic Health - The PREMIER Study1R21HL143030-01 | Cistola, David Paul | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER, TX | First-year cost $114,750 | Study section ZHL1 |
| FY2018 | Clinical analysis of Trem-Like Transcript-1 in large cohorts of patients from the NHLBI Biorepository1R21HL140268-01A1 | Washington, A. Valance | UNIVERSITY OF PUERTO RICO RIO PIEDRAS, PR | First-year cost $112,500 | Study section ZHL1 |
| FY2017 | Predicting Incident Stroke Using Blood Biomarkers of Brain Injury1R21HL140274-01 | Korley, Frederick Kofi | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $137,974 | Study section ZHL1 |
| FY2017 | Biomarkers for risk of chronic Graft-Versus-Host Disease occurrence1R21HL139934-01 | Paczesny, Sophie | INDIANA UNIVERSITY INDIANAPOLIS, IN | First-year cost $131,813 | Study section ZHL1 |
| FY2017 | Circulating Exosome microRNA as Markers of Severe Sarcoidosis Phenotypes1R21HL140012-01 | Crouser, Elliott D | OHIO STATE UNIVERSITY, OH | First-year cost $122,628 | Study section ZHL1 |
| FY2017 | Modeling Marfan Syndrome with iSMC-based Tissue-engineered Blood Vessel1R21HL140275-01 | Leong, Kam W | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $120,000 | Study section ZHL1 |
| FY2017 | Latexin in human hematopoietic stem cell expansion1R21HL140213-01 | Liang, Ying | UNIVERSITY OF KENTUCKY, KY | First-year cost $114,750 | Study section ZHL1 |
| FY2017 | Origin and evolution of virome in development of post-transfusion hepatitis1R21HL140269-01 | Kapoor, Amit | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | First-year cost $113,625 | Study section ZHL1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-16-0.3.5. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.